$WASH

WASHINGTON TRUST BANCORP INC (WASH): Results of Operations and Financial Condition

WASHINGTON TRUST BANCORP INC (WASH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit9912026q2.htm EX-99.1 Document Exhibit 99.1 NASDAQ: WASH Media Contact: Kathleen Hart VP, Public Relations Manager Telephone: (401) 348-1495 E-mail: kahart@washtrust.com Date: July 20, 2026 FOR IMMEDIATE RELEASE Washington Trust Reports Second Quarter 2026 Result

Original reporting
Published Jul 20, 2026, 8:08 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 20, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$WASH
Bullish
medium confidence
Mentioned
$WASH
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$WASHBullishMed
01

Why it matters

Traders can update near-term expectations for earnings power via the stated permanent improvement to net interest margin/run-rate starting Q3, while monitoring asset quality (past-due and nonaccrual) and provisioning trajectory.

02

Market read

Fresh Q2 earnings and balance-sheet metrics plus a specific Q3 earnings run-rate change (end of hedge amortization) create a tradable update for WASH.

03

What to watch

Investors may underweight the magnitude of the past-due increase and the shift in provision/charge-offs, and overemphasize NIM without assessing whether loan yield and funding costs normalize after the hedge benefit ends.

Relevance 7/10Novelty 6/10Timing: after-hours, filed July 20, 2026 with Q2 2026 results and Q3 run-rate implications

Background

This is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting Washington Trust Bancorp’s second quarter 2026 results and financial condition.

Company-level read

Ticker impact

$WASHBullishMedium confidence
Context

Washington Trust reported Q2 2026 net income of $16.0M, NIM of 2.73%, and deposit growth of 4% QoQ in its 8-K results release.

Expected impact

Near-term bias modestly positive if investors focus on the permanent earnings/margin improvement and stable capital, though credit metrics (past-due increase) may temper enthusiasm.

Evidence & confidence

Key incremental items include the cessation of deferred hedge loss amortization starting Q3 (removing $1.4M benefit from Q2 into a permanent run-rate improvement), plus updated NIM, deposits, and ACL/nonaccrual figures. However, the article lacks forward guidance beyond qualitative outlook, and past-due loans rose due to a single CRE loan, which can be a swing factor.

Market effects

Adds another regional bank datapoint on NIM resilience, deposit growth, and credit provisioning trends.

Relevant for Rhode Island and New England community/regional banking sentiment, but not systemically material.

Limited global relevance; primarily impacts regional bank peers via read-across on funding and credit costs.

Counterpoint

The headline profitability strength may be partly explained by the hedge amortization cessation benefit, while credit quality shows mixed signals with past-due loans rising sharply (even if attributed to one CRE loan).

Key entities

  • Washington Trust Bancorp, Inc.

    Nasdaq-listed regional bank reporting Q2 2026 net income, NIM, deposit/loan growth, and asset quality metrics.

  • Edward O. “Ned” Handy III

    Chairman and CEO quoted on performance, institutional banking growth, and outlook for 2026.

Related articles

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.